Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Polymyositis associated with infliximab treatment for rheumatoid arthritis.

Literature DB >> 17165006

Polymyositis associated with infliximab treatment for rheumatoid arthritis.

Yukitomo Urata, Yuji Wakai, Kenji Kowatari, Taisuke Nitobe, Yutaka Mizushima.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2006 PMID： 17165006 DOI： 10.1007/s10165-006-0523-1

Source DB: PubMed Journal: Mod Rheumatol ISSN： 1439-7595 Impact factor: 3.023

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?

Authors: Takao Nagashima; Seiji Minota
Journal: Clin Rheumatol Date: 2010-04-20 Impact factor: 2.980

2. A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis.

Authors: Adam Schiffenbauer; Megha Garg; Christine Castro; Angelina Pokrovnichka; Galen Joe; Joseph Shrader; Imelda Victoria Cabalar; Sara Faghihi-Kashani; Michael O Harris-Love; Paul H Plotz; Frederick W Miller; Mark Gourley
Journal: Semin Arthritis Rheum Date: 2017-10-16 Impact factor: 5.532

3. Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature.

Authors: Yuki Ishikawa; Naoichiro Yukawa; Koichiro Ohmura; Yuji Hosono; Yoshitaka Imura; Daisuke Kawabata; Takaki Nojima; Takao Fujii; Takashi Usui; Tsuneyo Mimori
Journal: Clin Rheumatol Date: 2010-02-09 Impact factor: 2.980

Review 4. Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Authors: Lorenzo Cavagna; Laura Nuño; Carlo Alberto Scirè; Marcello Govoni; Francisco Javier Lopez Longo; Franco Franceschini; Rossella Neri; Santos Castañeda; Walter Alberto Sifuentes Giraldo; Roberto Caporali; Florenzo Iannone; Enrico Fusaro; Giuseppe Paolazzi; Raffaele Pellerito; Andreas Schwarting; Lesley Ann Saketkoo; Norberto Ortego-Centeno; Luca Quartuccio; Elena Bartoloni; Christof Specker; Trinitario Pina Murcia; Renato La Corte; Federica Furini; Valentina Foschi; Javier Bachiller Corral; Paolo Airò; Ilaria Cavazzana; Julia Martínez-Barrio; Michelle Hinojosa; Margherita Giannini; Simone Barsotti; Julia Menke; Kostantinos Triantafyllias; Rosetta Vitetta; Alessandra Russo; Laura Bogliolo; Gianluigi Bajocchi; Elena Bravi; Giovanni Barausse; Roberto Bortolotti; Carlo Selmi; Simone Parisi; Fausto Salaffi; Carlomaurizio Montecucco; Miguel Angel González-Gay
Journal: Clin Rev Allergy Immunol Date: 2017-02 Impact factor: 8.667

Review 5. The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.

Authors: Angela Ceribelli; Maria De Santis; Natasa Isailovic; M Eric Gershwin; Carlo Selmi
Journal: Clin Rev Allergy Immunol Date: 2017-02 Impact factor: 8.667

6. A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept.

Authors: Yuki Ishikawa; Naoichiro Yukawa; Daisuke Kawabata; Koichiro Ohmura; Takao Fujii; Takashi Usui; Tsuneyo Mimori
Journal: Clin Rheumatol Date: 2011-01-11 Impact factor: 2.980

Polymyositis associated with infliximab treatment for rheumatoid arthritis.

1. Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?

2. A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis.

3. Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature.

Review 4. Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Review 5. The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.

6. A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept.

Review 7. Novel Therapeutic Options in Treatment of Idiopathic Inflammatory Myopathies.

Review 8. Cutaneous dermatomyositis in the era of biologicals.

Review 9. Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.

Review 10. Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies.